Page last updated: 2024-08-24

cidofovir anhydrous and Hepatitis

cidofovir anhydrous has been researched along with Hepatitis in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baba, HA; Ballauf, A; Breddemann, A; Dohna-Schwake, C; Fiedler, M; Gerner, P; Gierenz, N; Hoyer, PF; Läer, S1
Cimsit, B; Emre, S; Patel, SB; Rosencrantz, R; Tichy, EM1

Other Studies

2 other study(ies) available for cidofovir anhydrous and Hepatitis

ArticleYear
Primary HHV 6 infection after liver transplantation with acute graft rejection and multi-organ failure: successful treatment with a 2.5-fold dose of cidofovir and reduction of immunosuppression.
    Pediatric transplantation, 2011, Volume: 15, Issue:6

    Topics: Antiviral Agents; Child, Preschool; Cholestasis, Intrahepatic; Cidofovir; Cytosine; Female; Graft Rejection; Hepatitis; Herpesviridae Infections; Herpesvirus 6, Human; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Liver Cirrhosis; Liver Transplantation; Necrosis; Organophosphonates

2011
Treatment of adenovirus hepatitis with cidofovir in a pediatric liver transplant recipient.
    Pediatric transplantation, 2012, Volume: 16, Issue:3

    Topics: Adenoviridae; Antiviral Agents; Biopsy; Cidofovir; Cytosine; DNA; Hepatitis; Humans; Infant; Kidney; Liver Transplantation; Male; Organophosphonates; Polymerase Chain Reaction; Retrospective Studies; Risk Factors; Treatment Outcome

2012